Bascom Palmer Eye Institute is a center for ophthalmic care, research, and education at the University of Miami's Leonard M. Miller School of Medicine in Miami, in the United States.

There are 56 beds in Bascom Palmer Eye Institute.

During the past decade, Bascom Palmer Eye Institute conducted 60 clinical trials. In the 10-year time frame, 60 clinical trials started and 37 clinical trials were completed, i.e. on average, 61.7% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 20 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bascom Palmer Eye Institute" #1 sponsor was "University of Miami" with 26 trials, followed by "Neurotech Pharmaceuticals" with 5 trials sponsored, "Applied Genetic Technologies Corp" with 4 trials sponsored, "Astellas Institute for Regenerative Medicine" with 4 trials sponsored and "JHSPH Center for Clinical Trials" with 4 trials sponsored. Other sponsors include 72 different institutions and companies that sponsored additional 61 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bascom Palmer Eye Institute" #1 collaborator was "National Eye Institute (NEI)" with 20 trials as a collaborator, "Bascom Palmer Eye Institute" with 6 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator, "National Institutes of Health (NIH)" with 3 trials as a collaborator and "United States Department of Defense" with 3 trials as a collaborator. Other collaborators include 68 different institutions and companies that were collaborators in the rest 68 trials.

According to Clinical.Site data, the most researched conditions in "Bascom Palmer Eye Institute" are "Glaucoma" (11 trials), "Retinitis Pigmentosa" (6 trials), "Thyroid Eye Disease" (5 trials), "Uveitis" (5 trials) and "Cytomegalovirus Retinitis" (4 trials). Many other conditions were trialed in "Bascom Palmer Eye Institute" in a lesser frequency.

Most popular intervention types in "Bascom Palmer Eye Institute" are "Drug" (66 trials), "Device" (19 trials), "Biological" (17 trials), "Other" (17 trials) and "Procedure" (11 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "MA09-hRPE" (4 trials), "Teprotumumab" (4 trials), "Sham Procedure" (3 trials) and "Acetazolamide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Bascom Palmer Eye Institute" are 118 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Bascom Palmer Eye Institute". 1 are not yet recruiting, 11 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 74 completed trials in Bascom Palmer Eye Institute, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Bascom Palmer Eye Institute, 18 "Phase 1" clinical trials were conducted, 36 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 17 trials that are defined as “Not Applicable".

Bascom Palmer Eye Institute has several departments that took part in Clinical trials: "University of Miami Miller School of Medicine-Sylvester Cancer Center" - 753 trials, "Univ of Miami (Pediatric)" - 41 trials, "University of Miami Dept. of Neurology" - 4 trials, "University of Miami School of Medicine; Dept. of Neurology Movement Disorder Center" - 2 trials, "UM UHealth Pediatrics at the Professional Arts Center" - 2 trials, "University of Miami / Clinical Research Services, Inc." - 2 trials, "UM Pediatric Mobile Clinic" - 2 trials, "Miami Center for Cardiovascular Disease" - 2 trials